Rongchang Bio received approval from the Hong Kong Stock Exchange to remove the 'B' from its ticker symbol.
On June 7, Rongchang Biological announced that it has received approval from the Hong Kong Stock Exchange and will officially remove the "B" mark from the stock code in the near future.
Rongchang believes that the removal of the "B" mark is seen as an important sign of the development of an 18A biotech company. The "B" means that Rong Chang Biological has reached a higher standard in terms of market value and income, which is another milestone in its history of development.
Rongchang Biological said that in the future, it will make strides toward the goal of becoming a "leading Chinese and world-class" biopharmaceutical company, create more world-class new drugs for patients in China and the world, and create greater value for shareholders and society.
You May Interested In
2026-09-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Kraton Announces Strategic Plan to Streamline Polymer Operations in Berre, France
-
Sulfur Price Hits 7,633 CNY/Ton, Up Nearly Sixfold in a Year and a Half; Domestic Refining Giants Halt New Orders Due to Tight Supply
-
Chung Lien Oil’s 8,000-Ton Soybean Oil BaP Scandal: NT$165 Million Fine, 401 Product Recalls, Source Still Unknown
-
Hormuz Closes, Paint Feels It First: How a Barrel of Oil Rewrites the Cost of Every Barrel of Coatings
-
“Amputation or Strategic Retreat?”: Shell’s Six-Year Chemical Losses and the Quiet Unwinding of an Empire
-
Hormuz in Crisis: Freight Rates Surge to $6,000 as Global Trade Feels the Shock
-
“The 40-Year Ethylene Giant Collapses”: ExxonMobil’s Premature Shutdown Is Not Just Scotland’s Tragedy—It’s the Twilight Elegy of European Industrial Civilization
-
Titanium Dioxide Prices Are Up Again! This Round of Increases Has One Real Driver: Sulfuric Acid
-
Laboratoire PYC showcases its collagen-driven nutricosmetic innovations
-
Kemira to Acquire SIDRA Wasserchemie, Expanding European Water Treatment Footprint
Recommend Reading
-
![Smog Becomes a Sales Catalyst as Respiratory Drugs Surge in November]()
Smog Becomes a Sales Catalyst as Respiratory Drugs Surge in November
-
![A New Obesity Pill Enters the Arena With Double-Digit Weight Loss]()
A New Obesity Pill Enters the Arena With Double-Digit Weight Loss
-
![Wegovy Slips on Price While Mounjaro Defends Its Weight-Loss Crown]()
Wegovy Slips on Price While Mounjaro Defends Its Weight-Loss Crown
-
![Vertex Pushes Gene Therapy Into Younger Children With Blood Disorders]()
Vertex Pushes Gene Therapy Into Younger Children With Blood Disorders
-
![Lilly’s Mounjaro Enters China’s State Insurance System]()
Lilly’s Mounjaro Enters China’s State Insurance System
-
![Bullish Support, October Hydrogen Peroxide Prices Rise in China]()
Bullish Support, October Hydrogen Peroxide Prices Rise in China
-
![Soda Ash Market Trends Remain Stable]()
Soda Ash Market Trends Remain Stable
-
![Supply and Demand Game: Flexible Trends in the Chinese Melamine Market]()
Supply and Demand Game: Flexible Trends in the Chinese Melamine Market
-
![Ammonium Sulfate Market Trend in October Shows a Strong Increase in China]()
Ammonium Sulfate Market Trend in October Shows a Strong Increase in China
-
![Premium Global Chemical Sourcing Requests (28-31May, 2026)]()
Premium Global Chemical Sourcing Requests (28-31May, 2026)
